CMS Ends $3.6B Medicare Drug Subsidy, UnitedHealth Braces for 2027 Hit
UNH sits 82% above its 52-week low of $234.6.
Summary
The CMS is ending the Medicare Part D Premium Stabilization Demonstration after 2026, pulling a subsidy that provided $3.6B this year and $9.8B over two years. More than half of the 2027 funding would have gone to UnitedHealth, making it the biggest loser. The program had cut Part D premiums by 40% in 2025 and 27% in 2026; its removal will likely push premiums higher for many seniors starting in 2027, potentially reducing enrollment or pressuring margins. This follows UnitedHealth's strong Q2 beat and raised guidance, but the subsidy loss introduces a new headwind for its Medicare business. The administration argues insurers no longer need the support, but the shift could reshape the Part D competitive landscape.
At the time of this announcement, UNH was trading at $426.42 on NYSE in the Life Sciences sector, with a market capitalization of approximately $389.4B. The 52-week trading range was $234.60 to $461.62. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Benzinga.